Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Weighted-average Assumptions to Determine Fair Value

The weighted-average assumptions utilized to determine the fair value of options granted to employees are presented in the following table:

	Year Ended December 31,
	2024		2023		2022
Expected volatility	61.8	%	63.1	%	53.3	%
Weighted-average risk-free interest rate	4.28	%	3.75	%	2.72	%
Expected dividend yield	—		—		—
Expected life – in years	6		6		6

Schedule of Option Activity

A summary of the Company’s option activity as of December 31, 2024, and changes during the year then ended are as follows:

	Number of Options	Weighted-Average Exercise Price (per share)		Weighted-Average Remaining Contractual Term (in years)
Outstanding at December 31, 2023	7,175,494	$	7.02	7.78
Granted	15,888	12.62
Exercised	(1,534,375)	2.68
Forfeited	(390,844)	9.21
Outstanding at December 31, 2024	5,266,163	8.14		7.08
Options exercisable at December 31, 2024	3,424,709	7.03		6.56

Schedule of RSU Activity

A summary of RSU activity under the Company’s 2021 Plan for the year ended December 31, 2024 is as follows:

	Number of Shares	Weighted-Average Grant Date Fair Value		Aggregate Fair Value
Unvested balance at January 1, 2024	2,571,318	$	9.88	$	25,405
Granted	3,474,700	12.69		44,094
Vested	(1,197,503)	9.90		11,855
Forfeited	(325,016)	10.04		3,263
Unvested balance as of December 31, 2024	4,523,499	$	12.02	$	54,372

Schedule of PSU Activity

A summary of PSU activity under the Company’s 2021 Plan for the year ended December 31, 2024 is as follows:

	Number of Shares	Weighted-Average Grant Date Fair Value		Aggregate Fair Value
Unvested balance at January 1, 2024	1,077,726	$	11.61	$	12,512
Granted	1,173,681	12.58		14,765
Vested	—	—		—
Forfeited	(99,474)	10.05		1,000
Unvested balance at December 31, 2024	2,151,933	$	12.21	$	26,275

Schedule of Stock-based Compensation Expense

The following table shows stock-based compensation expense by where the stock-based compensation expense is recorded by line item in the Company’s consolidated statements of operations:

	For the Year Ended December 31,
	2024		2023		2022
Cost of revenue	$	239	$	130	$	74
Sales and marketing	4,742		3,077		2,235
Research and development	5,906		2,213		1,123
General and administrative	17,112		9,917		3,961
Total stock-based compensation	$	27,999	$	15,337	$	7,393